Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12338287 | Treatment of cancer using a CD33 chimeric antigen receptor | Hilmar Erhard Ebersbach, Thomas Huber, Julia Jascur, Reshma Singh, Huijuan Song +2 more | 2025-06-24 |
| 12214037 | Treatment of cancer using humanized anti-BCMA chimeric antigen receptor | Jennifer Brogdon, Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet +9 more | 2025-02-04 |
| 12037583 | Compositions and methods for immunooncology | Ming-Wei Chen, Melissa Deck, Glenn Dranoff, Craig Stephen MICKANIN, Reynald Michael Lescarbeau +2 more | 2024-07-16 |
| 11666642 | PDE5 compositions and methods for immunotherapy | Vipin Suri, Byron DeLaBarre, Michael N. Gladstone, Brian Dolinski, Abhishek Kulkarni +5 more | 2023-06-06 |
| 11241485 | PDE5 compositions and methods for immunotherapy | Vipin Suri, Byron DeLaBarre, Michael N. Gladstone, Brian Dolinski, Abhishek Kulkarni +5 more | 2022-02-08 |
| 11084880 | Anti-BCMA chimeric antigen receptor | Jennifer Brogdon, Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet +9 more | 2021-08-10 |
| 11058725 | CA2 compositions and methods for tunable regulation | Kutlu Goksu Elpek, Dhruv Kam Sethi, Meghan C. Langley, Tucker Read EZELL, Dexue Sun +11 more | 2021-07-13 |
| 10851166 | Treatment of cancer using a CD33 chimeric antigen receptor | Hilmar Erhard Ebersbach, Thomas Huber, Julia Jascur, Reshma Singh, Huijuan Song +2 more | 2020-12-01 |
| 10568947 | Treatment of cancer using a CLL-1 chimeric antigen receptor | Jennifer Brogdon, Hilmar Erhard Ebersbach, Saar Gill, David Glass, Julia Jascur +9 more | 2020-02-25 |
| 10174095 | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor | Jennifer Brogdon, Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet +9 more | 2019-01-08 |
| 9777061 | Treatment of cancer using a CD33 chimeric antigen receptor | Hilmar Erhard Ebersbach, Thomas Huber, Julia Jascur, Reshma Singh, Huijuan Song +2 more | 2017-10-03 |